Breaking News

Tweet TWEET

Law Office of Brodsky & Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc. and JDA Software Group, Inc.

      Law Office of Brodsky & Smith, LLC Announces Investigation of DUSA
              Pharmaceuticals, Inc. and JDA Software Group, Inc.

PR Newswire

BALA CYNWYD, Pa., Nov. 10, 2012

BALA CYNWYD, Pa., Nov. 10, 2012 /PRNewswire/ --Law office of Brodsky & Smith,
LLC announces that it is investigating potential claims against the Board of
Directors of DUSA Pharmaceuticals, Inc. ("DUSA" or the "Company") (Nasdaq-
DUSA-News) relating to the proposed acquisition by Sun Pharmaceutical
Industries Ltd. ("Sun").

Under the terms of the transaction, DUSA shareholders will receive only $8.00
in cash for each share of DUSA stock they own. The transaction may undervalue
the Company and will not result in any substantial gain for many DUSA
shareholders as DUSA stock traded at $7.00 on October 16, 2012. In addition,
an analyst has set a $9.50 per share price target for DUSA.

If you own shares of DUSA stock and have any questions, you may e-mail or call
the law office of Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact Jason L. Brodsky,
Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/501-dusa-dusa-pharmaceuticals-inc.html, by calling
toll free 877-LEGAL-90.

Investigation of JDA Software Group, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of JDA Software Group, Inc.
("JDA Software" or the "Company") (Nasdaq- JDAS-News) relating to the proposed
acquisition by RedPrairie Corporation. ("RedPrairie"). Under the terms of the
transaction, JDA Software shareholders will receive only $45.00 in cash for
each share on JDA Software common stock they own. The investigation concerns
possible breaches of fiduciary duty and other violations of state law by the
Board of Directors of JDA Software for not acting in the Company's
shareholders' best interests in connection with the sale process to
RedPrairie.

If you own shares of JDA Software stock and have any questions, you may e-mail
or call the law office of Brodsky & Smith, LLC who will, without obligation or
cost to you, attempt to answer your questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala
Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/496-jdas-jda-software-group-inc.html, by calling toll
free 877-LEGAL-90.

Attorney Advertising. Past results do not guarantee a similar outcome.

SOURCE Brodsky & Smith, LLC

Website: http://www.brodsky-smith.com